Detalhe da pesquisa
1.
Emerging Therapeutics, Technologies, and Drug Development Strategies to Address Patient Nonadherence and Improve Tuberculosis Treatment.
Annu Rev Pharmacol Toxicol
; 62: 197-210, 2022 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34591605
2.
Twice-Daily Dolutegravir Based Antiretroviral Therapy with One Month of Daily Rifapentine and Isoniazid (1HP) for TB Prevention.
Clin Infect Dis
; 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38568956
3.
Development of New Tuberculosis Drugs: Translation to Regimen Composition for Drug-Sensitive and Multidrug-Resistant Tuberculosis.
Annu Rev Pharmacol Toxicol
; 61: 495-516, 2021 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32806997
4.
Inpatient pain alleviation after orthopaedic trauma surgery-are we doing a good job?
Eur J Orthop Surg Traumatol
; 34(1): 569-576, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37650973
5.
Analysis of Dynamic Efficacy Endpoints of the Nix-TB Trial.
Clin Infect Dis
; 76(11): 1903-1910, 2023 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36804834
6.
Rifapentine With and Without Moxifloxacin for Pulmonary Tuberculosis in People With Human Immunodeficiency Virus (S31/A5349).
Clin Infect Dis
; 76(3): e580-e589, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36041016
7.
Pharmacokinetic Model of Tenofovir and Emtricitabine and Their Intracellular Metabolites in Patients in the ANRS 134-COPHAR 3 Trial Using Dose Records.
Antimicrob Agents Chemother
; 67(5): e0233918, 2023 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37098914
8.
QT Interval Prolongation with One or More QT-Prolonging Agents Used as Part of a Multidrug Regimen for Rifampicin-Resistant Tuberculosis Treatment: Findings from Two Pediatric Studies.
Antimicrob Agents Chemother
; 67(7): e0144822, 2023 07 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37358463
9.
Translational predictions of phase 2a first-in-patient efficacy studies for antituberculosis drugs.
Eur Respir J
; 62(2)2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37321622
10.
Target product profiles: tests for tuberculosis treatment monitoring and optimization.
Bull World Health Organ
; 101(11): 730-737, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37961060
11.
Pharmacokinetics and Safety of 3 Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women.
Clin Infect Dis
; 74(9): 1604-1613, 2022 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34323955
12.
Combination of Mycobacterium tuberculosis RS Ratio and CFU Improves the Ability of Murine Efficacy Experiments to Distinguish between Drug Treatments.
Antimicrob Agents Chemother
; 66(4): e0231021, 2022 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35311519
13.
A Rapid Pharmacogenomic Assay to Detect NAT2 Polymorphisms and Guide Isoniazid Dosing for Tuberculosis Treatment.
Am J Respir Crit Care Med
; 204(11): 1317-1326, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34375564
14.
Pharmacodynamic Correlates of Linezolid Activity and Toxicity in Murine Models of Tuberculosis.
J Infect Dis
; 223(11): 1855-1864, 2021 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31993638
15.
Coronavirus Disease 2019 (COVID-19) Pharmacologic Treatments for Children: Research Priorities and Approach to Pediatric Studies.
Clin Infect Dis
; 72(6): 1067-1073, 2021 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32594142
16.
Comparative Efficacy of Rifapentine Alone and in Combination with Isoniazid for Latent Tuberculosis Infection: a Translational Pharmacokinetic-Pharmacodynamic Modeling Study.
Antimicrob Agents Chemother
; 65(12): e0170521, 2021 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34606336
17.
Decreased plasma rifapentine concentrations associated with AADAC single nucleotide polymorphism in adults with tuberculosis.
J Antimicrob Chemother
; 76(3): 582-586, 2021 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33374006
18.
Mechanistic Modeling of Mycobacterium tuberculosis Infection in Murine Models for Drug and Vaccine Efficacy Studies.
Antimicrob Agents Chemother
; 64(3)2020 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31907182
19.
The importance of adherence in tuberculosis treatment clinical trials and its relevance in explanatory and pragmatic trials.
PLoS Med
; 16(12): e1002884, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31821323
20.
Pharmacokinetics, optimal dosing, and safety of linezolid in children with multidrug-resistant tuberculosis: Combined data from two prospective observational studies.
PLoS Med
; 16(4): e1002789, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31039153